Clinical and genetic characteristics predict outcomes of acute myeloid leukemia patients with FLT3 mutations receiving venetoclax-based therapy.

Guangyang WengJingya HuangNa AnYu ZhangGuopan YuZhiqiang SunDongjun LinLan DengXinquan LiangJie XiaoHongyu ZhangZiwen GuoXin HeHua Jin Qi-Fa LiuXin Du

Published in: Cancer medicine (2024)

patients receiving VEN-based therapy.

Keyphrases

acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
type diabetes
tyrosine kinase
genome wide
metabolic syndrome
adipose tissue
cell therapy
chronic lymphocytic leukemia